Lobbying disclosures · Lobbying report
CNC: third_quarter 2026 lobbying report
Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare issues related to healthcare affordability Regulatory policy related to LTC pharmaceutical services
Follow CNC- Became public
- Oct 17, 2026, 2:31 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 5:48 AM EST
Why this is connected
Legal-name match: CENTENE CORPORATION is CENTENE CORP (https://www.sec.gov/Archives/edgar/data/1071739/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/a0e919dd-4942-4497-adc1-e7c7ab245c74/","filing_uuid":"a0e919dd-4942-4497-adc1-e7c7ab245c74","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/a0e919dd-4942-4497-adc1-e7c7ab245c74/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Moschella, Attorney at Law","dt_posted":"2026-10-17T14:31:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"600 Massachusetts Ave, NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":7257,"url":"https://lda.gov/api/v1/registrants/7257/","house_registrant_id":31842,"name":"BROWNSTEIN HYATT FARBER SCHRECK, LLP","description":"Law firm","address_1":"600 Massachusetts Ave, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"QUINN MCKAY","contact_telephone":"+1 202-872-5292","dt_updated":"2026-07-30T12:03:37.302760-04:00"},"client":{"id":110300,"url":"https://lda.gov/api/v1/clients/110300/","client_id":1008974,"name":"CENTENE CORPORATION","general_description":"Health insurance","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"MO","ppb_state_display":"Missouri","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to ACA, Medicare Advantage, and Medicaid Issues related to Artificial Intelligence in healthcare issues related to healthcare affordability Regulatory policy related to LTC pharmaceutical services","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69369,"prefix":null,"prefix_display":null,"first_name":"NADEAM","nickname":null,"middle_name":null,"last_name":"ELSHAMI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70425,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"FELDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103206,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"STEINMETZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143000,"prefix":null,"prefix_display":null,"first_name":"DEEMA","nickname":null,"middle_name":null,"last_name":"TARAZI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150555,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":"ALEXANDRA","last_name":"MISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69972,"prefix":null,"prefix_display":null,"first_name":"RUSSELL","nickname":null,"middle_name":"W.","last_name":"SULLIVAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69159,"prefix":null,"prefix_display":null,"first_name":"HAROLD","nickname":null,"middle_name":null,"last_name":"HANCOCK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155119,"prefix":null,"prefix_display":null,"first_name":"SARA","nickname":null,"middle_name":null,"last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":"Principal Deputy Assistant Secretary for Legislation at the Department of Health and Human Services; Deputy Assistant Secretary for Legislation at the Department of Health and Human Services","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in CNC
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Aug 8, 2025 · disclosed Jan 13, 2026 · filed 158 days later
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Apr 14, 2025 · disclosed Jan 13, 2026 · filed 274 days later
- Sep 12, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 5, 2025 · disclosed Sep 12, 2025
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
- Sep 3, 2025$100K–$250K
- Sep 3, 2025$1K–$15K
- Sep 3, 2025$15K–$50K
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.